Outlook Therapeutics
Stock Forecast, Prediction & Price Target
Outlook Therapeutics Financial Estimates
Outlook Therapeutics Revenue Estimates
Outlook Therapeutics EBITDA Estimates
Outlook Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 9/30/2022 | 9/30/2023 | 9/30/2024 | 9/30/2025 | 9/30/2026 | 9/30/2027 | 9/30/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $9.53M Low: $3.76M High: $15.21M avg. 0% | Avg: $61.02M Low: $25.71M High: $91.61M avg. 540.09% | Avg: $204.48M Low: $86.16M High: $306.96M avg. 235.07% | Avg: $403.15M Low: $169.87M High: $605.20M avg. 97.15% |
Net Income
% change YoY
| $-66.05M N/A | $-58.98M 10.70% | $-75.36T -127777629.55% | Avg: $-64.38M Low: $-31.39M High: $-25.01M avg. 99.99% | Avg: $-25.52M Low: $-19.88M High: $-5.87M avg. 60.35% | Avg: $30.83M Low: $7.64M High: $50.92M avg. 220.78% | Avg: $76.67M Low: $18.99M High: $126.63M avg. 148.68% |
EBITDA
% change YoY
| $-62.91M N/A | $-57.37M 8.80% | $-71.70T -124970828.57% | Avg: $5.72M Low: $2.25M High: $9.12M avg. 100.00% | Avg: $36.61M Low: $15.42M High: $54.96M avg. 540.09% | Avg: $122.69M Low: $51.69M High: $184.17M avg. 235.07% | Avg: $241.89M Low: $101.92M High: $363.12M avg. 97.15% |
EPS
% change YoY
| -$6.23 N/A | -$4.72 24.23% | -$4,063.16 -85983.89% | Avg: -$2.23 Low: -$2.51 High: -$2 avg. 99.94% | Avg: -$0.95 Low: -$1.59 High: -$0.47 avg. 57.39% | Avg: $2.47 Low: $0.61 High: $4.07 avg. 359.47% | Avg: $6.13 Low: $1.52 High: $10.12 avg. 148.68% |
Operating Expenses
% change YoY
| $63.07M N/A | $53.12M -15.76% | $71.70T 134967184.23% | Avg: $8.91M Low: $3.51M High: $14.23M avg. -99.99% | Avg: $57.09M Low: $24.05M High: $85.70M avg. 540.09% | Avg: $191.31M Low: $80.61M High: $287.19M avg. 235.07% | Avg: $377.19M Low: $158.93M High: $566.22M avg. 97.15% |
FAQ
What is Outlook Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 132.45% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -31.39M, average is -64.38M and high is -25.01M.
What is Outlook Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 218.08% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $3.76M, average is $9.53M and high is $15.21M.
What is Outlook Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 166.37% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$2.51, average is -$2.23 and high is $-2.
What is the best performing analyst?
In the last twelve months analysts have been covering Outlook Therapeutics stock. The most successful analyst is Daniil Gataulin whose win rate is 100%. He has correctly predicted 1/1 price targets.